Latest News about ABCL
Recent news which mentions ABCL
From Benzinga
From Benzinga
Why AbCellera Biologics Rallied as Much as 24% on Wednesday
August 10, 2022
Tickers
ABCL
From Motley Fool
Why Plug Power Is Trading Higher By Around 14%, Here Are 73 Stocks Moving In Wednesday's Mid-Day Session
August 10, 2022
From Benzinga
From Benzinga
AbCellera Biologics Inc. (ABCL) Q2 2022 Earnings Call Transcript
August 10, 2022
Tickers
ABCL
From Motley Fool
From Benzinga
Why AbCellera Biologics Is 10% Lower Today
May 11, 2022
From Motley Fool
Tickers
ABCL
From Motley Fool
3 Biotech Stocks Under $10 to Add to Your Buy List
April 26, 2022
From InvestorPlace
AbCellera Biologics Inc. (ABCL) Q4 2021 Earnings Call Transcript
February 25, 2022
Tickers
ABCL
From Motley Fool
The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company
February 24, 2022
From Benzinga
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
February 20, 2022
From Benzinga
From Benzinga
Is It Time to Buy the Nasdaq's 11 Worst-Performing Stocks of 2021?
December 08, 2021
From Motley Fool
Lilly's COVID-19 Antibody Cocktail Scores FDA Emergency Use For Kids, Including Newborns
December 06, 2021
From Benzinga
These Biotech Companies Are Attempting to Use Improved Antibody Technology in the Fight To Eradicate COVID-19
November 29, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 19, 2021
November 19, 2021
From Benzinga
AbCellera Biologics Inc. (ABCL) Q3 2021 Earnings Call Transcript
November 10, 2021
Tickers
ABCL
From Motley Fool
How Bad Are AbCellera Biologics's Earnings? | Return On Capital Employed
November 09, 2021
Tickers
ABCL
From Benzinga
Why AbCellera Biologics Stock Sank 21.6% in October
November 04, 2021
From Motley Fool
Why AbCellera Biologics Stock Jumped 19.4% Last Month
October 07, 2021
From Motley Fool
AbCellera, Everest Medicines Team Up To Develop 10 Therapeutic Antibodies
September 23, 2021
Tickers
ABCL
From Benzinga
The Daily Biotech Pulse: Restricted Authorization For Pfizer's COVID-19 Booster Dose, AbCellera Strikes Antibody Licensing Deal, Solid Biosciences Issues DMD Data
September 23, 2021
From Benzinga
Cramer's Advice On Ulta Beauty, Laredo Petroleum And More
September 23, 2021
From Benzinga
The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera's COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold
September 17, 2021
From Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
September 17, 2021
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.